Analyse court terme - SARTORIUS STEDIM BIOTECH : Les prix se dirigent vers la borne basse du rectangle.
La tendance est toujours baissière, son niveau d'invalidation est au-dessus de 62,50 €. L'objectif est à 52,60 €.Arguments :
- Les prix se dirigent vers la borne basse du rectangle.
DayByDay is an independent research company providing global macro and single stock analysis, recommendation and allocation based purely on behavioural finance methods. Those include long term cycle analysis, sentiment analysis, and technical trigger. DayByDay serves all clients in need of practical and precise publications to make effective market decisions, on any time horizon, from a few hours to a few years.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.